$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

Liposome-gel compositions 원문보기

IPC분류정보
국가/구분 United States(US) Patent 등록
국제특허분류(IPC7판)
  • A61K-043/00
  • A61K-049/00
출원번호 US-0695887 (1985-01-31)
발명자 / 주소
  • Popescu Mircea C. (Plainsboro NJ) Weiner Alan L. (Plainsboro NJ) Carpenter-Green Sharon S. (East Windsor NJ)
출원인 / 주소
  • The Liposome Company, Inc. (Princeton NJ 02)
인용정보 피인용 횟수 : 193  인용 특허 : 10

초록

Compositions and methods for maintaining reservoirs of bioactive agents by sequestering the reservoir in a gel matrix are described. In particular, liposomes containing an entrapped bioactive agent are sequestered in a gel matrix. The resulting liposome-gel compositions may be used in vivo or in vit

대표청구항

A liposome-gel composition comprising a bioactive agent entrapped in liposomes sequestered in a gel matrix in which: (a) the gel matrix has a pore size relative to the liposomes so that the liposomes are sequestered in the gel matrix without blocking (i) diffusion of fluids into the gel which intera

이 특허에 인용된 특허 (10)

  1. Schmer Gottfried (Seattle WA), Bio-artificial organ using microencapsulated enzymes.
  2. Marshall Joseph W. (1617 Beverly Blvd. Los Angeles CA 90026), Composition with selectively active modifier and method.
  3. Tkes Zoltn A. (Los Angeles CA) Rogers Kathryn E. (Pasadena CA) Rembaum Alan (Pasadena CA), Drug delivery by polymeric carriers.
  4. Urquhart John (Palo Alto CA) Theeuwes Felix (Los Altos CA), Drug delivery system comprising a reservoir containing a plurality of tiny pills.
  5. Trimnell Donald (Peoria IL) Shasha Baruch S. (Peoria IL), Encapsulation by entrapment within polyhydroxy polymer borates.
  6. Geho, Walter B., Lipid membrane drug delivery.
  7. Baldeschwieler John D. (Pasadena CA) Gamble Ronald C. (Pasadena CA) Mauk Marcia R. (Vancouver NJ CAX) Shen Tsung-Ying (Westfield NJ) Ponpipom Mitree M. (Branchburg NJ), Lipid vesicles bearing carbohydrate surfaces as lymphatic directed vehicles for therapeutic and diagnostic substances.
  8. Baldeschwieler John D. (Pasadena CA) Gamble Ronald C. (Pasadena CA) Mauk Marcia R. (Vancouver CAX), Means of preparation and applications of liposomes containing high concentrations of entrapped ionic species.
  9. Zolle Ilse (Lazarettgasse 14A Vienna 1090 OE), Method for incorporating substances into protein microspheres.
  10. Iwasaki Hiroshi (Kawanishi JA) Shioi Shunsuke (Daito JA) Kouno Jujiro (Takatsuki JA), Process for producing microcapsules.

이 특허를 인용한 특허 (193)

  1. Chancellor,Michael B.; Fraser,Matthew O.; Chuang,Yao Chi; de Groat,William C.; Huang,Leaf; Yoshimura,Naoki, Application of lipid vehicles and use for drug delivery.
  2. Kiser, Patrick F.; Thomas, Allen A., Biodegradable cross-linkers having a polyacid connected to reactive groups for cross-linking polymer filaments.
  3. Marx Gerard (New York NY), Biologic bioadhesive compositions containing fibrin glue and liposomes, methods of preparation and use.
  4. Marx Gerard (New York NY), Biologic bioadhesive compositions containing fibrin glue and liposomes, methods of preparation and use.
  5. Marx Gerard (New York NY), Biologic bioadhesive compositions containing fibrin glue and liposomes, methods of preparation and use.
  6. Perricone, Nicholas V., Brain and neural treatments comprising peptides and other compositions.
  7. Perricone, Nicholas V., Brain and neural treatments comprising peptides and other compositions.
  8. Perricone, Nicholas V., Brain and neural treatments comprising peptides and other compositions.
  9. Perricone, Nicholas V., Brain and neural treatments comprising peptides and other compositions.
  10. Perricone, Nicholas V., Cancer treatments and compositions for use thereof.
  11. Perricone, Nicholas V., Cancer treatments and compositions for use thereof.
  12. Perricone, Nicholas V., Cancer treatments and compositions for use thereof.
  13. Winnicki, Robert, Cannabinoid formulations.
  14. Perricone, Nicholas V., Cardiovascular disease treatment and prevention.
  15. Perricone, Nicholas V., Cardiovascular disease treatment and prevention.
  16. Perricone, Nicholas V., Cardiovascular disease treatment and prevention.
  17. Perricone, Nicholas V., Cardiovascular disease treatment and prevention.
  18. Perricone, Nicholas V., Cardiovascular disease treatment and prevention.
  19. Chen, Guohua; Houston, Paul R.; Kleiner, Lothar; Spaltro, John, Catheter injectable depot compositions and uses thereof.
  20. Hayward James A. ; Watkins David C., Composition containing protease separate from glycosidase for removing nits in treating lice infestation.
  21. Lu, Michelle Zheng; Kalafsky, Robert E.; Duggan, Michele C., Compositions and delivery methods for the treatment of wrinkles, fine lines and hyperhidrosis.
  22. Perricone, Nicholas V., Compositions and methods for affecting mood states.
  23. Perricone, Nicholas V., Compositions and methods for affecting mood states.
  24. Perricone, Nicholas V., Compositions and methods for affecting mood states.
  25. Inna Yegorova, Compositions and methods for reducing or controlling blood cholesterol, lipoproteins, triglycerides and atherosclerosis.
  26. Inna Yegorova, Compositions and methods for reducing or controlling blood cholesterol, lipoproteins, triglycerides and atherosclerosis.
  27. Yegorova, Inna, Compositions and methods for reducing or controlling blood cholesterol, lipoproteins, triglycerides and atherosclerosis.
  28. Yegorova, Inna, Compositions and methods for reducing or controlling blood cholesterol, lipoproteins, triglycerides and atherosclerosis.
  29. Yegorova, Inna, Compositions and methods for reducing or controlling blood cholesterol, lipoproteins, triglycerides and atherosclerosis.
  30. Yegorova, Inna, Compositions and methods for reducing or controlling blood cholesterol, lipoproteins, triglycerides and atherosclerosis.
  31. Perricone, Nicholas V., Compositions and methods for treatment of osteoporosis and other indications.
  32. Perricone, Nicholas V., Compositions and methods for treatment of osteoporosis and other indications.
  33. Perricone, Nicholas V., Compositions and methods for treatment of osteoporosis and other indications.
  34. Perricone, Nicholas V., Compositions and methods for treatment of osteoporosis and other indications.
  35. Martynov, Artur; Farber, Boris S.; Farber, Sonya Sophya; Sitenko, Aleksandr, Cosmetic and pharmaceutical compositions having modified proteins in the form of a supramolecular assembly.
  36. Hayward James A. (4 Chuck Ct. Port Jefferson NY 11777) Goldstein Mindy S. (31 Southwick Ct. Plainview NY 11803) Brown Miriam (275 Candee Ave. Sayville NY 11782) Ceccoli Joseph D. (26 Neil Dr. Farming, Cosmetic delivery system for salicylic acid and process for preparation of same.
  37. Mönks, Monika; Ibanez, Sybille; Evangelisti, Carmen; Gohla, Sven, Cosmetic or dermatological preparation comprising a nutrient medium phase.
  38. Kim Lewis ; Peichun Hsieh, Culturing cells in presence of amphipathic weak bases and/or cations and multiple drug resistance inhibitor containing reserpine.
  39. DeAngelis,Paul, DNA encoding hyaluronan synthase from Pasteurella multocida and methods of use.
  40. DeAngelis, Paul, DNA encoding hyaluronan synthase from and methods of use.
  41. DeAngelis,Paul, DNA encoding hyaluronan synthase fromand methods of use.
  42. Craig, Bradley D.; Kobussen, Gregory A., Dental filler and methods.
  43. Douglas Quong CA, Encapsulated active material immobilized in hydrogel microbeads.
  44. Wallach Donald F. H. (Brookline MA), Encapsulated ionophore growth factors.
  45. Baseeth, Shireen S.; Sebree, Bruce R., Food compositions comprising organogels.
  46. Lewis, Kim; Hsieh, Peichun, Formulation containing amphipathic weak base and/or amphipathic cation and multiple drug resistance inhibitor.
  47. Brodbeck, Kevin J.; Gaynor-Duarte, Ann T.; Shen, Theodore Tao-Ian, Gel composition and methods.
  48. Hauton ; deceased Jacques,FRX ITX by Jean-Christophe Hauton ; heir and legal representative ; Salles Jean-Pierre,FRX, Gelified microspheres, their method of preparation and their applications.
  49. Hauton Jacques,FRX ; Salles Jean-Pierre,FRX, Gelified microspheres, their method of preparation and their applications.
  50. Bawa Rajan ; Hall Rex E. ; Kabra Bhagwati P. ; Teague James E., Gelling ophthalmic compositions containing xanthan gum.
  51. Bawa Rajan ; Hall Rex E. ; Kabra Bhagwati P. ; Teague James E. ; Cagle Gerald D. ; Markwardt Kerry L. ; Shah Mandar V., Gelling ophthalmic compositions containing xanthan gum.
  52. Perricone, Nicholas V., Hair treatment systems and methods using peptides and other compositions.
  53. Perricone, Nicholas V., Hair treatment systems and methods using peptides and other compositions.
  54. Perricone, Nicholas V., Hair treatment systems and methods using peptides and other compositions.
  55. Boudreau, Nancy; Young, David M.; Myers, Cornelia, HoxD3, HoxA3 and HoxB3 compositions and methods for improved wound healing.
  56. Weigel,Paul H.; Kumari,Kshama; DeAngelis,Paul, Hyaluronan synthase gene and uses thereof.
  57. Weigel,Paul H.; Kumari,Kshama; DeAngelis,Paul, Hyaluronan synthase gene and uses thereof.
  58. Weigel,Paul H.; Kumari,Kshama; DeAngelis,Paul, Hyaluronan synthase gene and uses thereof.
  59. Weigel,Paul H.; Kumari,Kshama; DeAngelis,Paul, Hyaluronan synthase gene and uses thereof.
  60. Weigel,Paul H.; Kumari,Kshama; DeAngelis,Paul, Hyaluronan synthase gene and uses thereof.
  61. Weigel,Paul H.; Kumari,Kshama; DeAngelis,Paul, Hyaluronan synthase gene and uses thereof.
  62. Weigel,Paul H.; Kumari,Kshama; DeAngelis,Paul, Hyaluronan synthase gene and uses thereof.
  63. Weigel, Paul H.; Kumari, Kshama; DeAngelis, Paul, Hyaluronan synthase gene and uses therof.
  64. DeAngelis, Paul L.; Weigel, Paul H.; Kumari, Kshama, Hyaluronan synthase genes and expression thereof in Bacillus hosts.
  65. DeAngelis, Paul L.; Weigel, Paul H.; Kumari, Kshama, Hyaluronan synthase genes and expression thereof in bacillus hosts.
  66. DeAngelis,Paul L.; Weigel,Paul H.; Kumari,Kshama, Hyaluronan synthase genes and expression thereof inhosts.
  67. DeAngelis,Paul L.; Weigel,Paul H.; Kumari,Kshama, Hyaluronan synthase genes and expression thereof inhosts.
  68. Weigel,Paul H.; Kumari,Kshama, Hyaluronan synthases and methods of making and using same.
  69. Weigel, Paul H.; DeAngelis, Paul L.; Papaconstantinou, John, Hyaluronate synthase gene and uses thereof.
  70. Weigel, Paul H.; DeAngelis, Paul L.; Papaconstantinou, John, Hyaluronate synthase gene and uses thereof.
  71. Weigel,Paul H.; DeAngelis,Paul L.; Papaconstantinou,John, Hyaluronate synthase gene and uses thereof.
  72. Marriott, Christopher; Martin, Gary Peter; Brown, Marc Barry, Hyaluronic drug delivery system.
  73. Perricone, Nicholas V., Immune modulation using peptides and other compositions.
  74. Perricone, Nicholas V., Immune modulation using peptides and other compositions.
  75. Perricone, Nicholas V., Immune modulation using peptides and other compositions.
  76. Perricone, Nicholas V., Immune modulation using peptides and other compositions.
  77. Chen, Guohua; Houston, Paul R.; Kleiner, Lothar Walter; Spaltro, John J., Injectable depot compositions and uses thereof.
  78. Chen, Guohua; Houston, Paul; Kleiner, Lothar; Wright, Jeremy, Injectable multimodal polymer depot compositions and uses thereof.
  79. Hayward James A. ; Watkins David C. ; Aust Duncan T., Lipid vesicles formed with alkylammonium fatty acid salts.
  80. Watkins David C. ; Vichroski Thomas J. ; Hayward James A., Lipid vesicles formed with alkylammonium fatty acid salts.
  81. Richer LeRoy L. (San Gabriel CA), Liposomal vesicles for intraperitoneal administration of therapeutic agents.
  82. Manzo Robert P. ; Vollhardt Jurgen ; Malkan Nisha ; Friars Gary, Liposome encapsulated active agent dry powder composition.
  83. Manzo Robert P. ; Vollhardt Jurgen,DEX ; Malkan Nisha ; Friars Gary, Liposome encapsulated active agent dry powder composition.
  84. Naeff Rainer,CHX ; Delmenico Sandro,CHX ; Spycher Rene,CHX ; Corbo Mike ; Flother Frank,CHX, Liposome-based topical vitamin D formulation.
  85. Lagace, Jacqueline; Beaulac, Christian; Clement-Major, Sebastien, Low-rigidity liposomal formulation.
  86. Perricone, Nicholas V., Memory or learning improvement using peptide and other compositions.
  87. Perricone, Nicholas V., Memory or learning improvement using peptide and other compositions.
  88. Perricone, Nicholas V., Memory or learning improvement using peptide and other compositions.
  89. Ben-Hur Ehud ; Zuk Maria M. ; Chan Wai-Shun, Method and composition for hair removal.
  90. Sirhan, Motasim; Yan, John; Gertner, Kevin, Method and device for the treatment of vulnerable tissue site.
  91. See Jackie R. ; See Darryl M., Method for inducing a systemic immune response to a hepatitis antigen.
  92. See Jackie R. ; See Darryl M., Method for inducing a systemic immune response to an HIV antigen.
  93. See Jackie R. ; See Darryl M., Method for inducing a systemic immune response to an antigen.
  94. Soon-Shiong Patrick ; Desai Neil P. ; Heintz Roswitha E., Method for making cytoprotective, biocompatible, retrievable microcapsule containment systems.
  95. Fountain Michael W. (Knoxville TN), Method for making solvent dilution microcarriers.
  96. Perricone, Nicholas V., Methods and compositions for muscular and neuromuscular diseases.
  97. Perricone, Nicholas V., Methods and compositions for muscular and neuromuscular diseases.
  98. Perricone, Nicholas V., Methods and compositions for muscular and neuromuscular diseases.
  99. Perricone, Nicholas V., Methods and compositions for muscular and neuromuscular diseases.
  100. Perricone, Nicholas V., Methods and systems for treating or preventing cancer.
  101. Perricone, Nicholas V., Methods and systems for treating or preventing cancer.
  102. Perricone, Nicholas V., Methods and systems for treating or preventing cancer.
  103. Perricone, Nicholas V., Methods and systems for treating or preventing cancer.
  104. Perricone, Nicholas V., Methods and systems for treatment of inflammatory diseases with nitric oxide.
  105. Perricone, Nicholas V., Methods and systems for treatment of inflammatory diseases with nitric oxide.
  106. Perricone, Nicholas V., Methods and systems for treatment of inflammatory diseases with nitric oxide.
  107. Perricone, Nicholas V., Methods and systems for treatment of inflammatory diseases with nitric oxide.
  108. Perricone, Nicholas V.; Potini, Chim, Methods of delivering stable topical drug compositions.
  109. Perricone, Nicholas V.; Potini, Chim, Methods of delivering stable topical drug compositions.
  110. DeAngelis, Paul L.; Jing, Wei, Methods of producing hyaluronic acid and chimeric and hybrid glycosaminoglycan polymers.
  111. Weigel,Paul H.; DeAngelis,Paul L.; Kumari,Kshama, Methods of producing hyaluronic acid using a recombinant hyaluronan synthase gene.
  112. Atkins, Thomas J.; Rickey, Michael E.; Mesens, Jean, Microencapsulated 3-piperidinyl-substituted 1,2-benzisoxazoles and 1,2-benzisothiazoles.
  113. Modi Pankaj,CAX, Mixed liposome pharmaceutical formulation with amphiphiles and phospholipids.
  114. Perricone, Nicholas V., Peptide systems and methods for metabolic conditions.
  115. Perricone, Nicholas V., Peptide systems and methods for metabolic conditions.
  116. Perricone, Nicholas V., Peptide systems and methods for metabolic conditions.
  117. Perricone, Nicholas V., Peptide systems and methods for metabolic conditions.
  118. Perricone, Nicholas V., Peptide systems and methods for metabolic conditions.
  119. Kabra Bhagwati P., Pharmaceutical compositions containing a fluoroquinolone antibiotic drug and xanthan gum.
  120. Nuria Carreras Perdiguer ES; Jose Alberto Vallet Mas ES; Gemma Torrella Cabello ES, Pharmaceutical compositions containing tobramycin and xanthan gum.
  121. Forssen Eric A. (La Canada CA), Phospholipid delivery vehicle for aqueous-insoluble active ingredients.
  122. Chen, Andrew Xian; Chen, Hailiang, Phospholipid depot.
  123. Modi Pankaj,CAX, Phospholipid formulations.
  124. Counsell Raymond E. (Ann Arbor MI) Longino Marc A. (Ann Arbor MI) Weichert Jamey P. (Ann Arbor MI) Schwendner Susan P. (Ann Arbor MI), Polyiodinated triglyceride analogs as radiologic agents.
  125. Counsell Raymond E. (Ann Arbor MI) Longino Marc A. (Ann Arbor MI) Weichert Jamey P. (Ann Arbor MI) Schwendner Susan P. (Ann Arbor MI), Polyiodinated triglyceride analogs as radiologic agents.
  126. Huang Leaf (Knoxville TN), Preparation of solid core liposomes.
  127. Perricone, Nicholas V., Prevention and treatment of cardiovascular diseases using systems and methods for transdermal nitric oxide delivery.
  128. Perricone, Nicholas V., Prevention and treatment of cardiovascular diseases using systems and methods for transdermal nitric oxide delivery.
  129. Perricone, Nicholas V., Prevention and treatment of cardiovascular diseases using systems and methods for transdermal nitric oxide delivery.
  130. Jurgen Vollhardt ; Nisha Malkan ; Robert P. Manzo, Process for producing cosmetic and pharmaceutical formulations, and products comprising same.
  131. Vollhardt Jurgen,DEX ; Manzo Robert P. ; Malkan Nisha, Process for producing solid anhydrous composition, and pharmaceutical and cosmetic products comprising same.
  132. Ribier Alain,FRX ; Simonnet Jean-Thierry,FRX, Process for the stabilization of vesicles of amphiphilic lipid(s) and composition for topical application containing the said stabilized vesicles.
  133. Brown Gregory L. (Atlanta GA) Eiferman Richard (Louisville KY) Schultz Gregory L. (Louisville KY) Valenzuela ; Pablo D. T. (San Francisco CA), Promotion of corneal stroma wound healing with human epidermal growth factor prepared from recombinant DNA.
  134. Bossmann, Stefan H.; Troyer, Deryl L.; Basel, Matthew T.; Shrestha, Tej B.; Wang, Hongwang, Protease selective supramolecular assemblies.
  135. Modi Pankaj,CAX, Proteinic drug delivery system using aerosolized membrane-mimetic amphiphiles.
  136. Chen, Guohua; Priebe, David, Short duration depot formulations.
  137. Chen, Guohua; Priebe, David T., Short duration depot formulations.
  138. Chancellor, Michael B.; Tyagi, Pradeep; Fraser, Matthew O.; Chuang, Yao-Chi; de Groat, William C; Huang, Leaf; Yoshimura, Naoki, Sphingomyelin liposomes for the treatment of hyperactive bladder disorders.
  139. Aust Duncan T. ; Ross Michael A. ; Wilmott James M. ; Hayward James A., Stabilizing vitamin A derivatives by encapsulation in lipid vesicles formed with alkylammonium fatty acid salts.
  140. MacPhee Martin James ; Drohan William Nash ; Liau Gene ; Haudenschild Christian, Supplemented and unsupplemented tissue sealants, method of their production and use.
  141. MacPhee,Martin J.; Drohan,William N.; Liau,Gene; Nunez,Hernan; Burgess,Wilson H.; Hollinger,Jeffrey O.; Maciag,Thomas, Supplemented and unsupplemented tissue sealants, methods of their production and use.
  142. MacPhee,Martin J.; Drohan,William N.; Liau,Gene; Nunez,Hernan; Burgess,Wilson H.; Maciag,Thomas; Singh,Manish, Supplemented and unsupplemented tissue sealants, methods of their production and use.
  143. MacPhee,Martin James; Drohan,William Nash; Liau,Gene; Nunez,Hernan; Burgess,Wilson H.; Maciag,Thomas, Supplemented and unsupplemented tissue sealants, methods of their production and use.
  144. Drohan,William N.; MacPhee,Martin J.; Nunez,Hernan; Liau,Gene; Burgess,Wilson H.; Maciag,Thomas, Supplemented fibrin matrix delivery systems.
  145. Orsolini Piero,CHX ; Mauvernay Rolland-Yves,CHX ; Deghenghi Romano,CHX, Sustained and controlled release of water insoluble polypeptides.
  146. Wheatley Margaret A. (Arlington MA) Langer Robert S. (Somerville MA) Eisen Herman N. (Waban MA), System for delayed and pulsed release of biologically active substances.
  147. Wheatley Margaret A. (Arlington MA) Langer Robert S. (Somerville MA) Eisen Herman N. (Waban MA), System for delayed and pulsed release of biologically active substances.
  148. Perricone, Nicholas V., Systems and methods for delivery of peptides.
  149. Perricone, Nicholas V., Systems and methods for delivery of peptides.
  150. Perricone, Nicholas V., Systems and methods for delivery of peptides.
  151. Perricone, Nicholas V., Systems and methods for delivery of peptides.
  152. Perricone, Nicholas V., Systems and methods for delivery of peptides.
  153. Perricone, Nicholas V., Systems and methods for treatment of acne vulgaris and other conditions with a topical nitric oxide delivery system.
  154. Perricone, Nicholas V., Systems and methods for treatment of acne vulgaris and other conditions with a topical nitric oxide delivery system.
  155. Perricone, Nicholas V., Systems and methods for treatment of acne vulgaris and other conditions with a topical nitric oxide delivery system.
  156. Perricone, Nicholas V., Systems and methods for treatment of acne vulgaris and other conditions with a topical nitric oxide delivery system.
  157. Roth, Laurence A.; Herman, Stephen Jack, Targeted delivery via biodegradable polymers.
  158. DeAngelis,Paul L.; Jing,Wei, Targeted glycosaminoglycan polymers by polymer grafting and methods of making and using same.
  159. DeAngelis, Paul L.; Jing, Wei, Targeted glycosaminoglycan polymers by polymer grafting and methods of making and using the same.
  160. Perricone, Nicholas V., Techniques and systems for treatment of neuropathic pain and other indications.
  161. Perricone, Nicholas V., Techniques and systems for treatment of neuropathic pain and other indications.
  162. Perricone, Nicholas V., Techniques and systems for treatment of neuropathic pain and other indications.
  163. Perricone, Nicholas V., Techniques and systems for treatment of neuropathic pain and other indications.
  164. Gohla, Sven; Moenks, Monika; Ibanez, Sibylle; Evangelisti, Carmen, Tissue culture media used as a component of cosmetics.
  165. Perricone, Nicholas V.; Sayed, Yousry Abdelrehim, Topical nitric oxide systems and methods of use thereof.
  166. Perricone, Nicholas V.; Sayed, Yousry Abdelrehim, Topical nitric oxide systems and methods of use thereof.
  167. Perricone, Nicholas V.; Sayed, Yousry Abdelrehim, Topical nitric oxide systems and methods of use thereof.
  168. Perricone, Nicholas V., Topical systems and methods for treating sexual dysfunction.
  169. Perricone, Nicholas V., Topical systems and methods for treating sexual dysfunction.
  170. Perricone, Nicholas V., Topical systems and methods for treating sexual dysfunction.
  171. Perricone, Nicholas V., Topical systems and methods for treating sexual dysfunction.
  172. Perricone, Nicholas V., Treatment and prevention of learning and memory disorders.
  173. Perricone, Nicholas V., Treatment and prevention of learning and memory disorders.
  174. Perricone, Nicholas V., Treatment and prevention of learning and memory disorders.
  175. Perricone, Nicholas V., Treatment and prevention of learning and memory disorders.
  176. Perricone, Nicholas V., Treatment of skin and soft tissue infection with nitric oxide.
  177. Perricone, Nicholas V., Treatment of skin and soft tissue infection with nitric oxide.
  178. Perricone, Nicholas V., Treatment of skin and soft tissue infection with nitric oxide.
  179. Perricone, Nicholas V., Treatment of skin and soft tissue infection with nitric oxide.
  180. Perricone, Nicholas V., Treatment of skin, including aging skin, to improve appearance.
  181. Perricone, Nicholas V., Treatment of skin, including aging skin, to improve appearance.
  182. Perricone, Nicholas V., Treatment of skin, including aging skin, to improve appearance.
  183. Perricone, Nicholas V., Treatment of skin, including aging skin, to improve appearance.
  184. Perricone, Nicholas V., Treatment of skin, including aging skin, to improve appearance.
  185. Perricone, Nicholas V., Treatment of skin, including aging skin, to improve appearance.
  186. Perricone, Nicholas V., Wound healing using topical systems and methods.
  187. Perricone, Nicholas V., Wound healing using topical systems and methods.
  188. Perricone, Nicholas V., Wound healing using topical systems and methods.
  189. Perricone, Nicholas V., Wound healing using topical systems and methods.
  190. Perricone, Nicholas V., Wound healing using topical systems and methods.
  191. Perricone, Nicholas V., Wound healing using topical systems and methods.
  192. Podhajsky, Ronald J., Wound mediating device.
  193. Weigel,Paul H.; Kumari,Kshama; DeAngelis,Paul, hyaluronan synthase gene and expression thereof in.
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로